IP Library Granted Patent US 8,636,712
Granted Patent B2
US 8,636,712 · App. 13/214,141 · Granted Jan 28, 2014

Endovascular devices and methods

Inventors: Chad J. Kugler (Andover, MN); Robert E. Atkinson (White Bear Lake, MN)
Assignee: Bridgepoint Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,636,712
App. No.
13/214,141
Granted
Jan 28, 2014
Kind
B2
Abstract

Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.

Claims (7)

1. A method of treating a vascular wall defining a vascular lumen, the vascular wall comprising an intima and an adventitia, the method including:

inserting a catheter into the vascular lumen, the catheter including a first tubular member defining a first lumen, an inflatable member located about the first tubular member; and a second tubular member defining a second lumen having an outlet, the second tubular member adjacent an outer surface of the inflatable member;

inflating the inflatable member to move the second tubular member radially away from a central axis of the first tubular member; and

injecting fluid out of the outlet of the second lumen and into the vascular wall creates a subintimal space defined by the vascular wall.

2. The method of claim 1 , wherein the injection of fluid delaminates tissue layers in a subintimal space defined by the vascular wall.

3. The method of claim 1 , further including inserting a subintimal device into a subintimal space defined by the blood vessel wall via the second lumen of the second tubular member.

4. The method of claim 1 , wherein the fluid is injected between the intima and the adventitia of the vascular wall.

Assignments (1)
NUNC PRO TUNC ASSIGNMENT Recorded Mar 22, 2022
From: BRIDGEPOINT MEDICAL, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 059512/0160 →
Continuity (4)
Continuation 11518431 · Sep 11, 2006
Provisional Application 60716287 · Sep 12, 2005
Provisional Application 60717726 · Sep 15, 2005
Related Publication 20120071854A1 · Mar 22, 2012